DDDougba Noel Dago

Dougba Noel Dago

*This is an algorithmically generated author record based on publicly available information.

Dougba Noel Dago has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anticancer Drugs Pharmacogenomics in African Populations: A Scoping Review of Clinico-Molecular Data and Involvement in Personalized Medicine

    by Marc Donald Wilfried Adico, Tata Gnire Safiatou Coulibaly, Dramane Dagnogo, Mousso Savadogo, Wentoin Alimata Marie Pierre Daramcoum, Saraka Didier Martial Yao, Dougba Noel Dago, Foungotin Hamidou Coulibaly, Abdou Azaque Zouré, Bagora Bayala, et al.

    In recent decades, Africa has experienced an increase in cancer mortality rates. This challenge conducted to wide use of anticancer drugs but their efficacy and toxicity may vary depending on patient’s genetic characteristics. In this context, pharmacogenomics may play a crucial role in optimizing and personalizing these treatments in African populations, which have been very little studied so far in this field. The main objective of this scoping review is to identify clinical and molecular data concerning the influence of genetic variants on the efficacy and the toxicity of anticancer drugs in African populations. The scientific databases PubMed, Science Direct, and Google Scholar were used to search for articles published between January 2010 and December 2025. This review was conducted according to the Arksey and O’Malley framework in accordance with the PRISMA-ScR method (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Data on genes, variants, cancer type, drug, country, year of study publication, and clinical effects on patients were extracted. This information was used to highlight the effect of pharmacogenes on the response of anticancer drugs and their implication for personalized medicine. A total of 2397 articles were identified in the three databases. After eliminating duplicates and off-topic articles, 59 articles were selected. Among them, 30 were examined in full text, of which two were excluded due to the unavailability of the full text. Finally, 28 articles were selected for the qualitative analysis of this review. From these 28 articles, 58 variants spread over 41 genes were identified. The results revealed a geographical disparity in importance of the included research, with a strong one coming from North and Southern Africa. The ABCB1, CYP3A5, CYP2D6, SLC28A3, CYP2C9, CYP2B6, TPMT and MTHFR genes have been the most studied. They were significantly associated with the efficacy and toxicity of chemotherapeutic drugs in most studies. The most frequently analyzed anticancer drugs for their drug-gene associations include imatinib, tamoxifen and doxorubicin. Breast cancer, chronic myeloid leukemia and acute lymphoblastic leukemia have been the most studied types of cancer. The available pharmacogenomic data for cancer drugs remain insufficient to allow a real application of personalized medicine in the treatment of cancer on the continent. This study provides an overview of the current state and gaps in pharmacogenomic research of anticancer drugs in Africa. It is particularly intended for pharmacologic clinicians, oncologists and health decision-makers involved in cancer management on the African continent.

  • Open Access

    Agro-morphological Differential Expression between Maize and Soybean Crops under Rhizobacteria and/or Foliar Fertilizer Treatments

    by Sara Laetitia Elphège Gnangui, Dougba Noel Dago, Kouamé Antoine N' Guessan, Nafan Diarrassouba

    Background The differential response of maize and soybean to plant growth-promoting rhizobacteria (PGPR) and foliar fertilizers remains insufficiently characterized in arid tropical soils. In this study, we investigated the agro-morphological responses of maize ( Zea mays L.) and soybean ( Glycine max L.) to rhizobacteria ( Pseudomonas fluorescens and Bradyrhizobium sp.) and foliar fertilizer treatments under arid soil conditions. Methods Statistical comparative analysis between the two crops have been performed basin on the growth parameters assessed including stem diameter, plant height, leaf number, and leaves length across four treatments: untreated control (T0), rhizobacteria alone (T1), rhizobacteria plus foliar fertilizer (T2), and foliar fertilizer alone (T3). Results As expected, comparative analyses revealed, regardless applied treatment, significant initial differences, between maize and soybeans for all growth parameters, because of physiological and genetic differences of those crops. Specifically, maize and soybeans exhibited greater growth dynamism in (i) diameter and height, and as well (ii) in number of leaves, respectively. The same analysis revealed no significant agro-morphological difference regarding growth dynamism for soybean and maize leaves length feature. Differential treatment effects highlighted that T1 and T2 treatments substantially enhanced maize diameter and height relative to T0, whereas soybean responded more strongly to leaves number dynamism improvement under T3 treatment under T3 treatment. Fisher’s exact tests supported these trends, indicating variable but treatment-dependent differential expression patterns between crops. Overall, rhizobacteria-based treatments (T1 and T2) predominantly improved maize growth, whereas foliar fertilization (T3) had a greater influence on soybean leaves development. Conclusion These results highlight a distinct species-specific responsiveness, with maize being more sensitive to microbial stimulation and soybean benefiting primarily from foliar nutrient input. These findings support the development of crop-specific biofertilization strategies tailored to nutrient-poor arid soils in Northern Côte d’Ivoire (West Africa).

  • Open Access

    Agro-morphological Differential Expression between Maize and Soybean Crops under Rhizobacteria and/or Foliar Bio-fertilizer Treatments

    by Sara Laetitia Elphège Gnangui, Dougba Noel Dago, Kouamé Antoine N' Guessan, Nafan Diarrassouba

    Background The differential response of maize and soybean to plant growth-promoting rhizobacteria (PGPR) and foliar biofertilizers remains insufficiently characterized in arid tropical soils. In this study, we investigated the agro-morphological responses of maize ( Zea mays L.) and soybean ( Glycine max L.) to rhizobacteria ( Pseudomonas fluorescens and Bradyrhizobium sp.) and foliar biofertilizer treatments under arid soil conditions. Methods The growth parameters assessed included stem diameter, plant height, leaf number, and leaf length across four treatments: untreated control (T0), rhizobacteria alone (T1), rhizobacteria plus foliar bio-fertilizer (T2), and foliar bio-fertilizer alone (T3). Results Comparative analyses revealed significant baseline differences between maize and soybean for all parameters, with maize exhibiting superior diameter and height growth and soybean showing higher leaf number but shorter leaf length. Differential treatment effects highlighted that T1 and T2 substantially enhanced maize diameter and height relative to T0, whereas soybean responded more strongly to leaf number in T3. Fisher’s exact tests supported these trends, indicating variable but treatment-dependent differential expression patterns between crops. Overall, rhizobacteria-based treatments (T1 and T2) predominantly improved maize growth, whereas foliar fertilization (T3) had a greater influence on soybean leaf development. Conclusion These results highlight a distinct species-specific responsiveness, with maize being more sensitive to microbial stimulation and soybean benefiting primarily from foliar nutrient input. These findings support the development of crop-specific biofertilization strategies tailored to nutrient-poor arid soils in northern Cote d’Ivoire (West Africa).

  • Open Access

    Genome-wide association study of fat content and fatty acid composition of shea tree (Vitellaria paradoxa C.F. Gaertn subsp. paradoxa)

    by Affi Jean Paul Attikora, Kouakou Alfred Kouassi, Saraka Didier Martial Yao, Dougba Noel Dago, Souleymane Silué, Caroline De Clerck, Nafan Diarrassouba, Taofic Alabi, Enoch G. Achigan-Dako, Maurie-Laure Fauconnier, et al.

    Fat content (FC) and fatty acids (FA) are the most important traits in shea tree breeding, controlled by several genes with relatively small effects. Therefore, determining the genes involved in the biosynthesis of such traits is crucial for improving oil quantity and quality and for the domestication process of the species. To identify the quantitative trait nucleotides (QTNs) controlling FC and FA, we conducted a multi-locus genome-wide association study (GWAS) using six multi-locus GWAS methods for FC and FA in 122 superior shea trees (SSTs). SSTs were genotyped using DArTseq, resulting in 7,559 non-redundant single nucleotide polymorphism markers. Fat content varied from 36 to 58% with a mean of 50%. Fatty acid composition was 51.26 ± 4.21, 38.76 ± 4.67, 6.45 ± 0.76 and 3.53 ± 0.52% for oleic, stearic, linoleic and palmitic acids, respectively. A very high negative correlation coefficient (-0.98) was found between stearic and oleic acids. A total of 47 significant QTNs associated with fat-related traits were detected by the GWAS methods. Among these QTNs, 25 were identified as common QTNs based on their detection by multiple GWAS methods. Using the superior allele information of the 4 common QTNs associated with fat content in 17 high-fat and 21 low-fat SSTs, we found a higher percentage of superior alleles in SSTs with high FC (47.1%) than in SSTs with low FC (14.3%). Pathway analysis of the common QTNs identified 24 potential candidate genes likely involved in the biosynthesis of FC and FA composition in shea tree seeds. These findings will contribute to the discovery of the polygenic networks controlling FC in shea tree, improve our understanding of the genetic basis and regulation of FC, and be useful for molecular breeding of high-fat shea tree cultivars.


  • Open Access

    Polymorphism of the rs12255372 Allele of the TCF7L2 Gene Associated with Predisposition to Type 2 Diabete Using SNP Markers in a Population in the North of the Côte d’Ivoire

    by Dagnogo Oléfongo, Dago Noel, Yeo Korotoum, Kouman Angélo, Coulibaly David, Djaman Joseph

    Background : Type 2 diabetes (T2D) is a chronic metabolic disease characterised by hyperglycaemia due to insulin resistance and impaired insulin secretion. Genetic and environmental factors can influence predisposition to this disease. Genetic predisposition plays a significant role in the risk of developing the disease, and the TCF7L2 (T-Cell Factor-Like 2) gene is one of the main genes associated with type 2 diabetes. Objective: The aim of this study was to investigate the prevalence of the rs12255372 (G/T) polymorphism in TCF7L2, a gene associated with the risk of type 2 diabete (T2D) in the Ivorian population in the north of Côte d'Ivoire. Methodology : We included a total of 75 participants, 50 with type 2 diabete and 25 healthy subjects, for various anthropometric, clinical and genetic parameters. Participants were recruited from the Korhogo Regional Hospital. After obtaining consent, a blood sample was taken from each participant for glycaemia measurement and confetti realization for molecular biology. Genomic DNA extracted from the confetti was used to perform TCF7L2 gene genotyping using allele-specific PCR. Results : Analysis of the prevalence of the T allele of the SNP rs12255372 showed a statistically significant association between type 2 diabetic patients and non-diabetics (p≤0.05). The analysis revealed a genotypic prevalence of the rs12255372 variant of the TT allele significantly more expressed in non-diabetics (52%) compared with diabetics (26%) (p=0.03, z=2.23). Conclusion : This study revealed a high prevalence of the rs12255372 genetic variant of the TCF7L2 gene in non-diabetic populations in the north of Côte d'Ivoire, suggesting a significant predisposition to types 2 diabetes and the involvement of other factors, such as environmental conditions, lifestyle habits and genetic interactions in the development of type 2 diabetes in healthy subjects carrying the TT allele of the SNP rs12255372 of the TCF7L2 gene.

  • Open Access

    Assessment of Saliva and Urine Performance for Antimalarial Drug Resistance Molecular Markers Study

    by Dagnogo Oléfongo, Dago Noél, Kouman Angélo, Ako Bérenger, Bla Kouakou, Touré André, Djaman Joseph

    Background : The malaria diagnostic tools developed to date require blood to be taken. However, certain groups in the population are reluctant to take blood samples because of their cultural habits (blood taboo), or because of the fear associated with the trauma of the injection, especially when the sample is taken repeatedly. Saliva and urine, which are not very invasive to collect, have not been widely used for malaria diagnosis. The aim of this study is to assess the performance of saliva and urine in detecting molecular markers of Plasmodium falciparum resistance to antimalarial drugs. Methodology : Blood, urine and saliva samples were collected in three different localities from 94 patients over 2 years of age with microscopically confirmed Plasmodium falciparum uncomplicated malaria. P. falciparum genomic DNA (Deoxyribonucleic acid) was then extracted and amplified using primers specific for the Pfcrt (Plasmodium falciparum Chloroquine Resistance Transporter), Pfdhfr (Plasmodium falciparum dihydrofolate reductase) and PfK13 propeller (Plasmodium falciparum Kelch13 propeller) genes. The amplification products were processed by electrophoresis and analyzed against blood, saliva and urine samples. A multivariate statistical analysis in R programming environment was performed aiming to assess the performance of blood, saliva and urine samples in detecting molecular markers of P. falciparum resistance. Results : Agarose gel electrophoresis of the amplification products of each gene detected the Pfcrt genes at 80.85% (76/94), Pfdhfr at 95.74% (90/94) and PfK13 Propeller at 98.93% (93/94) in blood. In saliva, gene detection levels were 50% (47/94), 69.14% (65/94) and 4.26% (4/94) respectively for the K13 propeller, Pfdhfr and Pfcrt genes. Unlike the Pfcrt gene, which was not detected, 45.74% (43/94) and 38.30% (36/94) of PfK13 Propeller and pfdhfr genes respectively were detected in urine. Taking blood as the reference biological sample, statistical analysis showed that unlike urine, saliva exhibited a detection performance for molecular markers of antimalarial drug resistance ( pfcrt, pfdhfr , pfK13 propeller) close to that of blood (p < 0.05). The performance of saliva and urine was also assessed on the basis of the detection of the molecular markers pfdhfr , pfcrt and pfK13 using ROC ( receiver operational characteristic ) analysis. The data revealed a high sensitivity of saliva compared with urine in the detection of the pfdhfr , pfcrt and pfK13 propeller genes. Conclusion : The levels of detection of molecular markers of antimalarial drug resistance studied in saliva are close to those in blood. Saliva is a high-performance biological product that could potentially be used as an alternative non-invasive sample for the study of molecular markers of Plasmodium falciparum resistance to antimalarial drugs.


  • Open Access

    Genetic Variants Assessing Crohn’s Disease Pattern in Pediatric Inflammatory Bowel Disease Patients by a Clinical Exome Survey

    by Dago Dougba Noel, Pinelli Marinella, Giacomelli Mauro, Serena Ilaria Tripodi, Alessia Pin, Arrigo Serena, Bramuzzo Matteo, Fuoti Maurizio Giuseppe, Alvisi Patrizia, Calza Stefano, et al.

    Inflammatory bowel diseases (IBDs) are complex, multifactorial disorders that comprise Crohn’s disease (CD) and ulcerative colitis (UC). Recent discoveries have brought much attention to the genetic predisposition of patients with IBD. Here we evaluate the interaction between IBD genetic risk factors susceptibility and CD occurrence in an IBD pediatric patient population, performing a clinical exome survey. From February 2018 to April 2019, we collected blood samples from 7 pediatric patients with IBD concerns from several collaborating health centers and/or hospitals. Blood samples were processed by extracting and sequencing DNA for a clinical exome survey. Shophia-DDM-v3-4 platform allowed sequenced reads alignment on hg19 genome as well as genetic variant calling. Both IBD risk and pathogenic genetic variants covered by at least 20 reads were selected for subjacent analysis. Normality and Bartlett tests of both risk and pathogenic genetic variants suggested random and heterogeneous distribution of these variants in this group of IBD pediatric patients. P value clustering analysis by processing 157 IBD risk factors revealed genetic heterogeneity in IBD population and suggested two pathways influencing IBD development. In particular, (1) genetic variants associated with autoimmune and (2) metabolic diseases and CD risk factors (rs2066844 and rs2241880 single nucleotide polymorphism variants, respectively, of genes NOD2 and ATG16L) were identified in distinct clusters of IBD patients (P < .05). Moreover, the heterogeneous distribution of the following variants rs10065172 (IRGM), rs1805010 (IL4R), rs5030737 (MBL2), and rs33995883 (LRRK2) in this group of IBD patients was consistent with their random distribution in that population. Our study revealed specific genetic variants linked to CD susceptibility, autoimmune and/or innate immunodeficiency as well as to metabolic defects, as favoring factors of IBD, suggesting the valuable role of next generation sequencing (NGS) approaches in IBD molecular diagnostic procedures.